Congratulations to Jordan and Maddi, for being recognized in Dare to Discover campaign of the University of Iowa @uiowa The Dare to Discover campaign showcases researchers, scholars, and creators from across the University of Iowa
https://t.co/Dmn3rsbwRC
https://t.co/WrE4czrsOK
Check out our latest review on JAK-STAT signaling and JAK inhibition for #alopecia areata! This work is especially timely given the recent FDA approval of #baricitinib for patients with AA! Nicely done @LensingMaddi!
https://t.co/yGWewZ945T
New Research: An overview of JAK/STAT pathways and JAK inhibition in alopecia areata: Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair lossโฆ https://t.co/UTVr840IV7 #immunology
Today marks the first FDA approved treatment for AA! ๐คฉ Baricitinib is a dual JAK1/JAK2 inhibitor! #AlopeciaAreata#Jakinhibitor https://t.co/CrbvUiv5Hb